Cytena BPS

Acquired

High-Throughput Microbioreactor Systems for Bioprocessing

Taipei, Taiwan · Founded 2018 · $12.6M raised

Headquarters
Taipei
Employees
11–50
Founded
2018
Business Model
B2B
Total Funding
$12.6M
Last Round
$5.7M Extension RoundJan 2025
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Cytena BPS (now Leadgene Biosolutions) was a biotech instrumentation company founded in 2018 by engineers and scientists from the University of Freiburg's IMTEK Institute, supported by cytena GmbH (Germany) and operating within the BICO Group. The company specialized in advanced technologies for dynamic cell-culture control, high-throughput bioprocessing, and real-time culture monitoring, developing microbioreactor platforms (S.NEST, C.NEST) using patented pneumatic mixing technology that enables gentle, consistent, and scalable cell culture workflows. In 2025, following its transition out of the BICO Group, Cytena BPS integrated with Leadgene Biomedical (Taiwan) to form Leadgene Biosolutions, combining expertise in microfluidics, automation engineering, bioprocess design, assay development, and protein expression. The combined entity is headquartered in Taipei, Taiwan and serves pharmaceutical, cell therapy, and cultivated meat research markets globally.

Summary

Cytena BPS is a Biotech company based in Taipei, Taiwan, founded in 2018. It has raised $12.6M in total across 3 rounds, most recently a $5.7M Extension Round in Jan 2025. Investors include Darwin Ventures.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Extension RoundExtension Round2025 (est.)
$5.7M

Sign up to see all 3 events

Funding: Pre-Seed through Extension Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Cytena BPS on Indexed.vc
<a href="https://indexed.vc/companies/cytena-bps"><img src="https://indexed.vc/api/badge/company/cytena-bps" alt="Cytena BPS on Indexed.vc" width="260" height="76" /></a>